Enhancing viral vaccine production using engineered knockout vero cell lines – A second look
Hoeksema, F., Karpilow, J., Luitjens, A., Lagerwerf, F., Havenga, M., Groothuizen, M., Gillissen, G., Lemckert, A.A.C., Jiang, B., Tripp, R.A., Yallop, C.
Published in Vaccine (12.04.2018)
Published in Vaccine (12.04.2018)
Get full text
Journal Article
Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against Plasmodium yoelii in Mice
Ophorst, O. J. A. E, Radošević, K, Havenga, M. J. E, Pau, M. G, Holterman, L, Berkhout, B, Goudsmit, J, Tsuji, M
Published in Infection and Immunity (2006)
Published in Infection and Immunity (2006)
Get full text
Journal Article
Genetic diversity of Teratosphaeria pseudoeucalypti in Eucalyptus plantations in Australia and Uruguay
Aylward, J., Havenga, M., Dreyer, L. L., Roets, F., Wingfield, B. D., Pérez, C. A., Ramírez-Berrutti, N., Carnegie, A. J., Wingfield, M. J.
Published in Australasian plant pathology (01.11.2021)
Published in Australasian plant pathology (01.11.2021)
Get full text
Journal Article
Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity
Havenga, M.J.E, Holterman, L, Melis, I, Smits, S, Kaspers, J, Heemskerk, E, Vlugt, R. van der, Koldijk, M, Schouten, G.J, Hateboer, G, Brouwer, K, Vogels, R, Goudsmit, J
Published in Biotechnology and bioengineering (01.06.2008)
Published in Biotechnology and bioengineering (01.06.2008)
Get full text
Journal Article
Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease
Havenga, M J E, Lemckert, A A C, Ophorst, O J A E, van Meijer, M, Germeraad, W T V, Grimbergen, J, van Den Doel, M A, Vogels, R, van Deutekom, J, Janson, A A M, de Bruijn, J D, Uytdehaag, F, Quax, P H A, Logtenberg, T, Mehtali, M, Bout, A
Published in Journal of Virology (01.05.2002)
Published in Journal of Virology (01.05.2002)
Get full text
Journal Article
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells
Havenga, M, Vogels, R, Zuijdgeest, D, Radosevic, K, Mueller, S, Sieuwerts, M, Weichold, F, Damen, I, Kaspers, J, Lemckert, A, van Meerendonk, M, van der Vlugt, R, Holterman, L, Hone, D, Skeiky, Y, Mintardjo, R, Gillissen, G, Barouch, D, Sadoff, J, Goudsmit, J
Published in Journal of general virology (01.08.2006)
Published in Journal of general virology (01.08.2006)
Get full text
Journal Article
Improved Adenovirus Vectors for Infection of Cardiovascular Tissues
Havenga, M J, Lemckert, A A, Grimbergen, J M, Vogels, R, Huisman, L G, Valerio, D, Bout, A, Quax, P H
Published in Journal of Virology (01.04.2001)
Published in Journal of Virology (01.04.2001)
Get full text
Journal Article
Improved Gene Delivery to Intestinal Mucosa by Adenoviral Vectors Bearing Subgroup B and D Fibers
LECOLLINET, S, GAVARD, F, HAVENGA, M. J. E, SPILLER, O. B, LEMCKERT, A, GOUDSMIT, J, ELOIT, M, RICHARDSON, J
Published in Journal of Virology (01.03.2006)
Published in Journal of Virology (01.03.2006)
Get full text
Journal Article
Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs
Hartgroves, L.C.S, Koudstaal, W, McLeod, C, Moncorgé, O, Thompson, C.I, Ellis, J, Bull, C, Havenga, M.J.E, Goudsmit, J, Barclay, W.S
Published in Vaccine (09.04.2010)
Published in Vaccine (09.04.2010)
Get full text
Journal Article
Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma
Kuhlmann, K F D, van Geer, M A, Bakker, C T, Dekker, J E M, Havenga, M J E, Elferink, R P J Oude, Gouma, D J, Bosma, P J, Wesseling, J G
Published in Cancer gene therapy (01.07.2009)
Published in Cancer gene therapy (01.07.2009)
Get full text
Journal Article
Suitability of PER.C6® cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics
Koudstaal, W, Hartgroves, L, Havenga, M, Legastelois, I, Ophorst, C, Sieuwerts, M, Zuijdgeest, D, Vogels, R, Custers, J, de Boer-Luijtze, E, de Leeuw, O, Cornelissen, L, Goudsmit, J, Barclay, W
Published in Vaccine (28.04.2009)
Published in Vaccine (28.04.2009)
Get full text
Journal Article
Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells
Rea, Delphine, Havenga, Menzo J. E, van den Assem, Maayke, Sutmuller, Roger P. M, Lemckert, Angelique, Hoeben, Rob C, Bout, Abraham, Melief, Cornelis J. M, Offringa, Rienk
Published in The Journal of immunology (1950) (15.04.2001)
Published in The Journal of immunology (1950) (15.04.2001)
Get full text
Journal Article
Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients
Brouwer, E, Havenga, M J, Ophorst, O, de Leeuw, B, Gijsbers, L, Gillissen, G, Hoeben, R C, ter Horst, M, Nanda, D, Dirven, C, Avezaat, C J, Goudsmit, J, Sillevis Smitt, P
Published in Cancer gene therapy (01.02.2007)
Published in Cancer gene therapy (01.02.2007)
Get full text
Journal Article
Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1
Lamfers, M L.M, Grimbergen, J M, Aalders, M C, Havenga, M J, de Vries, M R, Huisman, L G.M, van Hinsbergh, V W.M, Quax, P H.A
Published in Circulation research (15.11.2002)
Published in Circulation research (15.11.2002)
Get full text
Journal Article
Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B
Knaän-Shanzer, S, Van Der Velde, I, Havenga, M J, Lemckert, A A, De Vries, A A, Valerio, D
Published in Human gene therapy (01.11.2001)
Published in Human gene therapy (01.11.2001)
Get more information
Journal Article